Fortrea Holdings (FTRE) Non-Current Debt (2023 - 2026)
Fortrea Holdings (FTRE) posted Non-Current Debt of $1.0 billion for Q1 2026, down 0.52% on a QoQ basis from $1.0 billion in Q4 2025, and down 0.7% year-over-year from $1.0 billion in Q1 2025.
Fortrea Holdings (FTRE) Non-Current Debt (2023 - 2026) Analysis & Trends
Fortrea Holdings' Non-Current Debt history runs 4 years deep, the most recent figure standing at $1.0 billion for Q1 2026.
- Quarterly Non-Current Debt fell 0.7% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (down 0.7% YoY) and the FY2025 annual result came in at $1.0 billion, changed 0.16% from the prior year.
- Non-Current Debt was $1.0 billion for Q1 2026 at Fortrea Holdings, down from $1.0 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $1.6 billion in Q2 2023 and bottomed at $1.0 billion in Q1 2026.
- A 4-year average of $1.2 billion and a median of $1.1 billion in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2024 — Non-Current Debt sank 32.97% — and 2025, when it decreased 0.16%.
- Fortrea Holdings' Non-Current Debt stood at $1.6 billion in 2023, then plunged by 32.97% to $1.0 billion in 2024, then fell by 0.16% to $1.0 billion in 2025, then declined by 0.52% to $1.0 billion in 2026.
- Business Quant data shows FTRE's Non-Current Debt at $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | 1.04 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 1.10 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.12 Bn |
| Mar 31, 2024 | 1.56 Bn |
| Dec 31, 2023 | 1.57 Bn |
| Sep 30, 2023 | 1.57 Bn |
| Jun 30, 2023 | 1.58 Bn |